HADDOCK2P2I: A Biophysical Model for Predicting the Binding Affinity of Protein–Protein Interaction Inhibitors

The HADDOCK score, a scoring function for both protein–protein and protein-nucleic acid modeling, has been successful in selecting near-native docking poses in a variety of cases, including those of the CAPRI blind prediction experiment. However, it has yet to be optimized for small molecules, and in particular inhibitors of protein–protein interactions, that constitute an “unmined gold reserve” for drug design ventures. We describe here HADDOCK2P2I, a biophysical model capable of predicting the binding affinity of protein–protein complex inhibitors close to experimental error (∼2-fold larger). The algorithm was trained and 4-fold cross-validated against experimental data for 27 inhibitors targeting 7 protein–protein complexes of various functions and tested on an independent set of 24 different inhibitors for which Kd/IC50 data are available. In addition, two popular ligand topology generation and parametrization methods (ACPYPE and PRODRG) were assessed. The resulting HADDOCK2P2I model, derived from the original HADDOCK score, provides insights into inhibition determinants: while the role of electrostatics and desolvation energies is case-dependent, the interface area plays a more critical role compared to protein–protein interactions.

[1]  C. Dominguez,et al.  HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. , 2003, Journal of the American Chemical Society.

[2]  Philippe Roche,et al.  2P2Idb: a structural database dedicated to orthosteric modulation of protein–protein interactions , 2012, Nucleic Acids Res..

[3]  Asher Mullard,et al.  Protein–protein interaction inhibitors get into the groove , 2012, Nature Reviews Drug Discovery.

[4]  Alexandre M J J Bonvin,et al.  Molecular origins of binding affinity: seeking the Archimedean point. , 2013, Current opinion in structural biology.

[5]  Wim F Vranken,et al.  ACPYPE - AnteChamber PYthon Parser interfacE , 2012, BMC Research Notes.

[6]  A. Bonvin,et al.  The HADDOCK web server for data-driven biomolecular docking , 2010, Nature Protocols.

[7]  B. Villoutreix,et al.  A leap into the chemical space of protein-protein interaction inhibitors. , 2012, Current pharmaceutical design.

[8]  K. P. Murphy,et al.  Thermodynamics of structural stability and cooperative folding behavior in proteins. , 1992, Advances in protein chemistry.

[9]  Philippe Roche,et al.  Atomic Analysis of Protein-Protein Interfaces with Known Inhibitors: The 2P2I Database , 2010, PloS one.

[10]  P. Colman,et al.  BCL-2 family antagonists for cancer therapy , 2008, Nature Reviews Drug Discovery.

[11]  Alexander D. MacKerell,et al.  Computational identification of inhibitors of protein-protein interactions. , 2007, Current topics in medicinal chemistry.

[12]  Alexandre M J J Bonvin,et al.  Are scoring functions in protein-protein docking ready to predict interactomes? Clues from a novel binding affinity benchmark. , 2010, Journal of proteome research.

[13]  Luhua Lai,et al.  SCORE: A New Empirical Method for Estimating the Binding Affinity of a Protein-Ligand Complex , 1998 .

[14]  W. L. Jorgensen,et al.  The OPLS [optimized potentials for liquid simulations] potential functions for proteins, energy minimizations for crystals of cyclic peptides and crambin. , 1988, Journal of the American Chemical Society.

[15]  I. Longden,et al.  EMBOSS: the European Molecular Biology Open Software Suite. , 2000, Trends in genetics : TIG.

[16]  Z. Weng,et al.  A structure‐based benchmark for protein–protein binding affinity , 2011, Protein science : a publication of the Protein Society.

[17]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[18]  C. E. Peishoff,et al.  A critical assessment of docking programs and scoring functions. , 2006, Journal of medicinal chemistry.

[19]  Olivier Sperandio,et al.  Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods , 2010, PLoS Comput. Biol..

[20]  David Ryan Koes,et al.  PocketQuery: protein–protein interaction inhibitor starting points from protein–protein interaction structure , 2012, Nucleic Acids Res..

[21]  Olivier Sperandio,et al.  iPPI-DB: a manually curated and interactive database of small non-peptide inhibitors of protein-protein interactions. , 2013, Drug discovery today.

[22]  William L. Jorgensen,et al.  Journal of Chemical Information and Modeling , 2005, J. Chem. Inf. Model..

[23]  Zhihai Liu,et al.  Comparative Assessment of Scoring Functions on a Diverse Test Set , 2009, J. Chem. Inf. Model..

[24]  Holger Gohlke,et al.  The Amber biomolecular simulation programs , 2005, J. Comput. Chem..

[25]  Alexandre M J J Bonvin,et al.  HADDOCK versus HADDOCK: New features and performance of HADDOCK2.0 on the CAPRI targets , 2007, Proteins.

[26]  David M. Wilson,et al.  Fragment-based discovery of bromodomain inhibitors part 2: optimization of phenylisoxazole sulfonamides. , 2012, Journal of medicinal chemistry.

[27]  Haruki Nakamura,et al.  Data Deposition and Annotation at the Worldwide Protein Data Bank , 2009, Molecular biotechnology.

[28]  David Ryan Koes,et al.  Small-molecule inhibitor starting points learned from protein–protein interaction inhibitor structure , 2011, Bioinform..

[29]  Matteo Magnani,et al.  Molecular Interaction Fields and 3D-QSAR Studies of p53-MDM2 Inhibitors Suggest Additional Features of Ligand-Target Interaction , 2010, J. Chem. Inf. Model..

[30]  Arieh Warshel,et al.  Absolute binding free energy calculations: On the accuracy of computational scoring of protein–ligand interactions , 2010, Proteins.

[31]  D J Rogers,et al.  A Computer Program for Classifying Plants. , 1960, Science.

[32]  Gary D Bader,et al.  The Genetic Landscape of a Cell , 2010, Science.

[33]  Ruhong Zhou,et al.  New Linear Interaction Method for Binding Affinity Calculations Using a Continuum Solvent Model , 2001 .

[34]  R. Meadows,et al.  Structure of Bcl-xL-Bak Peptide Complex: Recognition Between Regulators of Apoptosis , 1997, Science.

[35]  A. Barabasi,et al.  Interactome Networks and Human Disease , 2011, Cell.

[36]  Philippe Roche,et al.  Chemical and structural lessons from recent successes in protein-protein interaction inhibition (2P2I). , 2011, Current opinion in chemical biology.

[37]  P. Kastritis,et al.  On the binding affinity of macromolecular interactions: daring to ask why proteins interact , 2013, Journal of The Royal Society Interface.

[38]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[39]  Holger Gohlke,et al.  How Good Are State-of-the-Art Docking Tools in Predicting Ligand Binding Modes in Protein-Protein Interfaces? , 2012, J. Chem. Inf. Model..

[40]  Christus,et al.  A General Method Applicable to the Search for Similarities in the Amino Acid Sequence of Two Proteins , 2022 .

[41]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[42]  M. Gilson,et al.  Calculation of protein-ligand binding affinities. , 2007, Annual review of biophysics and biomolecular structure.

[43]  Holger Gohlke,et al.  Hot Spots and Transient Pockets: Predicting the Determinants of Small-Molecule Binding to a Protein-Protein Interface , 2012, J. Chem. Inf. Model..

[44]  S. Srinivasula,et al.  Mechanism of XIAP-mediated inhibition of caspase-9. , 2003, Molecular cell.

[45]  Yanli Wang,et al.  PubChem: Integrated Platform of Small Molecules and Biological Activities , 2008 .

[46]  R. Abagyan,et al.  Identification of protein-protein interaction sites from docking energy landscapes. , 2004, Journal of molecular biology.

[47]  Tjelvar S. G. Olsson,et al.  The thermodynamics of protein-ligand interaction and solvation: insights for ligand design. , 2008, Journal of molecular biology.

[48]  Philippe Derreumaux,et al.  Flexibility and binding affinity in protein–ligand, protein–protein and multi-component protein interactions: limitations of current computational approaches , 2012, Journal of The Royal Society Interface.

[49]  Y. Cheng,et al.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. , 1973, Biochemical pharmacology.

[50]  Grzegorz M. Popowicz,et al.  Enabling Large-Scale Design, Synthesis and Validation of Small Molecule Protein-Protein Antagonists , 2012, PloS one.